Morozova et al. (2019) also demonstrated that phosphomimetic recombinant tau and tau purified from AD brains induce neurotoxicity through muscarinic receptor subtype M1 and M3-dependent uptake in primary neurons and mouse hippocampus. Here, MAPT is linked to Alzheimer disease.